TaurelFinance, decoded
Live
Loading market data…
TTaurel

Genmab shares rise 4% on J&J cancer drug FDA approval

Investing.com· Investing.com· Nov 9, 2026 · 9:44 AM
Genmab shares rise 4% on J&J cancer drug FDA approval

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

European shares rise on banking boost
stocks26 minutes ago

European shares rise on banking boost

Investing.com

Outokumpu shares fall 5% after JPMorgan downgrade
stocks34 minutes ago

Outokumpu shares fall 5% after JPMorgan downgrade

Investing.com

JPMorgan adjusts Nordic bank ratings on margin pressure concerns
stocks35 minutes ago

JPMorgan adjusts Nordic bank ratings on margin pressure concerns

Investing.com